Caliway Unveils Latest OI25 Animal Study Data for CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies at ADA 2026, Demonstrating Dual Potential to Attenuate Post-Discontinuation Weight Regain and Improve Metabolic Health

by | PRNewswire Asia

Backed by International Authority — Caliway’s latest preclinical data on its proprietary localized fat reduction candidate, CBL-514, in combination with GLP–1R–based weight–loss therapies, were presented at the American Diabetes Association 2026 Scientific...

Manulife Asia Care Survey 2026: Independence as Asia's New Legacy

by | PRNewswire Asia

From living longer to living free, people across Asia prioritize health and financial self-sufficiency to pursue independence and avoid burdening loved ones HONG KONG, June 11, 2026 /PRNewswire/ — As longevity continues to rise across Asia, people are rethinking...

Elixiron Immunotherapeutics Reports Positive Phase 2 Interim Results for Enrupatinib: Evidence of Neuroinflammation Reduction and Early Cognitive Benefit in Alzheimer's Disease

by | PRNewswire Asia

CAMBRIDGE, Mass. and TAIPEI, June 11, 2026 /PRNewswire/ — Elixiron Immunotherapeutics (TPEx: 7871), a clinical-stage biopharmaceutical company pioneering precision immunotherapy for neurodegenerative and autoimmune diseases, today announced positive interim...

Link's "Hundred Flavours" Survey Decodes Hongkongers' Taste DNA — Tuen Mun Residents Have the Sweetest Tooth, While Hongkongers "Can Eat Bitter" but Shy Away from Spice

by | PRNewswire Asia

Mrs Mak and McDull Visit 24 Malls and Markets, Launching Exclusive Themed Premiums and Dining Offers The "Hundred Flavours Survey" drew over 6,000 participants, uncovering "unconventional" insights into the eating habits of residents across the...

Pantai Hospital Kuala Lumpur Launches AI-Powered Adaptive Radiotherapy System to Advance Personalised Cancer Care in Malaysia

by | PRNewswire Asia

Varian Ethos with HyperSight supports daily treatment adaptation, helping clinicians deliver more precise radiotherapy while reducing unnecessary exposure to healthy tissue  KUALA LUMPUR, Malaysia, June 10, 2026 /PRNewswire/ — Pantai Hospital Kuala...

ToolGen Opens Advanced Field Testing Facility in Osong, Completing 'Bench-to-Field' Commercialization Platform for Global SAF and Industrial Crop Markets

by | PRNewswire Asia

Establishes a regulatory-compliant, state-of-the-art Genome-Edited (GE) Crop Field Testing Facility to accelerate global commercialization. Enables comprehensive field evaluation of a diversified crop portfolio, including drought tolerance, herbicide tolerance, and...